Search Results - "Infectious diseases and therapy"
-
1
Effect and Safety of Meropenem–Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The TANGO II Randomized Clinical Trial
Published in Infectious diseases and therapy (01-12-2018)“…Introduction Treatment options for carbapenem-resistant Enterobacteriaceae (CRE) infections are limited and CRE infections remain associated with high clinical…”
Get full text
Journal Article -
2
In Vitro Bactericidal and Virucidal Efficacy of Povidone-Iodine Gargle/Mouthwash Against Respiratory and Oral Tract Pathogens
Published in Infectious diseases and therapy (01-06-2018)“…Introduction Recent virus epidemics and rising antibiotic resistance highlight the importance of hygiene measures to prevent and control outbreaks. We…”
Get full text
Journal Article -
3
Sixty years of Amphotericin B: An Overview of the Main Antifungal Agent Used to Treat Invasive Fungal Infections
Published in Infectious diseases and therapy (01-03-2021)“…Introduced in the late 1950s, polyenes represent the oldest family of antifungal drugs. The discovery of amphotericin B and its therapeutic uses is considered…”
Get full text
Journal Article -
4
Cefiderocol: A Novel Agent for the Management of Multidrug-Resistant Gram-Negative Organisms
Published in Infectious diseases and therapy (01-03-2020)“…Cefiderocol, formerly S-649266, is a first in its class, an injectable siderophore cephalosporin that combines a catechol-type siderophore and cephalosporin…”
Get full text
Journal Article -
5
Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosa
Published in Infectious diseases and therapy (01-04-2022)“…Multidrug-resistant (MDR) and extensively drug-resistant (XDR) Pseudomonas aeruginosa isolates are frequent causes of serious nosocomial infections that may…”
Get full text
Journal Article -
6
Povidone-Iodine Demonstrates Rapid In Vitro Virucidal Activity Against SARS-CoV-2, The Virus Causing COVID-19 Disease
Published in Infectious diseases and therapy (01-09-2020)“…Introduction As of 22 June 2020, Severe Acute Respiratory Syndrome (SARS)-coronavirus (CoV)-2 has infected more than 8.95 million people worldwide, causing >…”
Get full text
Journal Article -
7
Vaccines for SARS-CoV-2: Lessons from Other Coronavirus Strains
Published in Infectious diseases and therapy (01-06-2020)“…The emergence of the strain of coronavirus SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) and its impact on global health have made imperative…”
Get full text
Journal Article -
8
Continuous Evolution: Perspective on the Epidemiology of Carbapenemase Resistance Among Enterobacterales and Other Gram-Negative Bacteria
Published in Infectious diseases and therapy (01-03-2021)“…The global emergence of carbapenemase-producing bacteria capable of hydrolyzing the once effective carbapenem antibiotics is considered a contemporary public…”
Get full text
Journal Article -
9
Climate Change and Cascading Risks from Infectious Disease
Published in Infectious diseases and therapy (01-08-2022)“…Climate change is adversely affecting the burden of infectious disease throughout the world, which is a health security threat. Climate-sensitive infectious…”
Get full text
Journal Article -
10
Infections in Cancer Patients with Solid Tumors: A Review
Published in Infectious diseases and therapy (01-03-2017)“…Solid tumors are much more common than hematologic malignancies. Although severe and prolonged neutropenia is uncommon, several factors increase the risk of…”
Get full text
Journal Article -
11
Infectious Disease Management and Control with Povidone Iodine
Published in Infectious diseases and therapy (01-12-2019)“…With reports of vancomycin-resistant enterococci recently emerging in hospital settings, renewed focus is turning to the importance of multifaceted infection…”
Get full text
Journal Article -
12
Etiology of Severe Community-Acquired Pneumonia in Adults Based on Metagenomic Next-Generation Sequencing: A Prospective Multicenter Study
Published in Infectious diseases and therapy (01-12-2020)“…Background Metagenomic next-generation sequencing (mNGS) of bronchoalveolar lavage fluid (BALF) has the potential to improve the pathogen identification in…”
Get full text
Journal Article -
13
Candida auris Candidemia in Critically Ill, Colonized Patients: Cumulative Incidence and Risk Factors
Published in Infectious diseases and therapy (01-06-2022)“…Introduction Candida auris ( C. auris ) is an emerging nosocomial pathogen, and a sharp rise in cases of colonization and infection has been registered in…”
Get full text
Journal Article -
14
Coronavirus: Update Related to the Current Outbreak of COVID-19
Published in Infectious diseases and therapy (01-06-2020)“…In December 2019, some cases of viral pneumonia were epidemiologically related to a new coronavirus in the province of Hubei, China. Subsequently, there has…”
Get full text
Journal Article -
15
Coronavirus: Update Related to the Current Outbreak of COVID-19
Published in Infectious diseases and therapy (01-06-2020)“…In December 2019, some cases of viral pneumonia were epidemiologically related to a new coronavirus in the province of Hubei, China. Subsequently, there has…”
Get full text
Journal Article -
16
Defining the Epidemiology and Burden of Severe Respiratory Syncytial Virus Infection Among Infants and Children in Western Countries
Published in Infectious Diseases and Therapy (01-09-2016)“…Introduction The REGAL (RSV [respiratory syncytial virus] Evidence—a Geographical Archive of the Literature) series provides a comprehensive review of the…”
Get full text
Journal Article Book Review -
17
The Future of Respiratory Syncytial Virus Disease Prevention and Treatment
Published in Infectious diseases and therapy (01-03-2021)“…Respiratory syncytial virus (RSV) is a major cause of respiratory tract infections in infants, young children, and older or immunocompromised adults. Although…”
Get full text
Journal Article -
18
Efficacy of Bamlanivimab/Etesevimab and Casirivimab/Imdevimab in Preventing Progression to Severe COVID-19 and Role of Variants of Concern
Published in Infectious diseases and therapy (01-12-2021)“…Introduction The aim of this study was to evaluate the risk of hospitalization or death in patients infected by SARS-CoV2 variants of concern (VOCs) receiving…”
Get full text
Journal Article -
19
Ceftazidime-Avibactam for the Treatment of Serious Gram-Negative Infections with Limited Treatment Options: A Systematic Literature Review
Published in Infectious diseases and therapy (01-12-2021)“…Introduction A systematic literature review was undertaken to evaluate real-world use of ceftazidime-avibactam for infections due to aerobic Gram-negative…”
Get full text
Journal Article -
20
Metagenomic Next-Generation Sequencing for the Diagnosis of Pneumocystis jirovecii Pneumonia in Non-HIV-Infected Patients: A Retrospective Study
Published in Infectious diseases and therapy (01-09-2021)“…Introduction This study aimed to evaluate the utility of metagenomic next-generation sequencing (mNGS) for the diagnosis of Pneumocystis jirovecii pneumonia…”
Get full text
Journal Article